Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $36.15 Million |
|---|---|
| Enterprise Value | $35.20 Million |
| Earnings per Share | $- |
| Beta | 0.39 |
| Outstanding Shares | - |
| P/E Ratio | -4.28 |
|---|---|
| PEG | 48.5 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.6 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.04 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong pre...